Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Snowden

Showing results (221-230 of 250) with videos related to

Pageof 25
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 20, 2020
The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementiaJennifer A Saxon, Jennifer C Thompson, Jennifer M Harris, et al.
Acta Neuropathologica Communications|April 23, 2017
Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 geneYvonne S Davidson, Louis Flood, Andrew C Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Differential diagnosis of Alzheimer's disease using spectrochemical analysis of bloodMaria Paraskevaidi, Camilo L M Morais, Kássio M G Lima, et al.
Brain : a Journal of Neurology|March 30, 2004
Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau geneS M Pickering-Brown, M Baker, T Nonaka, et al.
Neuropathology and Applied Neurobiology|April 14, 2012
Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changesY S Davidson, A C Robinson, Q Hu, et al.
European Journal of Medicinal Chemistry|January 25, 2020
Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused libraryGarrett S Gibbons, Amarraj Chakraborty, Sierrah M Grigsby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2015
18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer diseaseChristopher Kobylecki, Tobias Langheinrich, Rainer Hinz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in malesR Srinivasan, Y Davidson, L Gibbons, et al.
Acta Neuropathologica|March 23, 2011
The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS geneJulie S Snowden, Quan Hu, Sara Rollinson, et al.
Acta Neuropathologica Communications|June 22, 2014
Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72Yvonne S Davidson, Holly Barker, Andrew C Robinson, et al.
Pageof 25

Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 20, 2020
The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementiaJennifer A Saxon, Jennifer C Thompson, Jennifer M Harris, et al.
Acta Neuropathologica Communications|April 23, 2017
Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 geneYvonne S Davidson, Louis Flood, Andrew C Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Differential diagnosis of Alzheimer's disease using spectrochemical analysis of bloodMaria Paraskevaidi, Camilo L M Morais, Kássio M G Lima, et al.
Brain : a Journal of Neurology|March 30, 2004
Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau geneS M Pickering-Brown, M Baker, T Nonaka, et al.
Neuropathology and Applied Neurobiology|April 14, 2012
Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changesY S Davidson, A C Robinson, Q Hu, et al.
European Journal of Medicinal Chemistry|January 25, 2020
Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused libraryGarrett S Gibbons, Amarraj Chakraborty, Sierrah M Grigsby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2015
18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer diseaseChristopher Kobylecki, Tobias Langheinrich, Rainer Hinz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in malesR Srinivasan, Y Davidson, L Gibbons, et al.
Acta Neuropathologica|March 23, 2011
The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS geneJulie S Snowden, Quan Hu, Sara Rollinson, et al.
Acta Neuropathologica Communications|June 22, 2014
Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72Yvonne S Davidson, Holly Barker, Andrew C Robinson, et al.
Pageof 25